R&D and Manufacturing
The company has obtained over 97 patents, including 80 invention patents, and has been granted 260 product approvals, including 82 for domestic chemical drugs, 121 for overseas preparation production permits in Europe and America, 44 for active pharmaceutical ingredient production permits and filings, and 8 for pharmaceutical excipient production permits and filings. Currently, there are over 150 ongoing research and development projects, involving first-to-file + patent challenge generic drugs, improved 505b(2) new drugs, and new entity compound drugs.
Domestic chemical drug approvals
Production permits for preparations to overseas markets
API production approvals